According to our research, high levels of HIF1A protein in GC are associated with T stage progression, TNM stage progression, lymph node metastasis, differentiated status, M stage progression, Borrmann stage progression, tumor size, vascular invasion, and positive VEGF protein expression, providing potential biological indicators for the diagnosis and prognosis of patients with GC. Here, HIF1A is linked to gastric cancer.